Subscribe to PRO at just Rs.33 per month. Use code SUPERPRO
you are here: HomeNewsBusiness
Last Updated : Aug 10, 2020 06:29 PM IST | Source: Moneycontrol.com

InterGlobe Aviation QIP: IndiGo operator to raise up to Rs 4,000 crore via share sale

The move comes as the company looks to manage cash during the COVID-19 pandemic which has hit its operations.

  • bselive
  • nselive
Todays L/H

InterGlobe Aviation Ltd, the operator of India's largest domestic carrier IndiGo, said on August 10 that it will raise up to Rs 4,000 crore ($533.70 million) through qualified institutional placement.

"The Board of Directors of lnterGlobe Aviation limited (the "Company"), at its meeting held today, i.e., August 10, 2020, has considered and approved the raising of funds for an aggregate amount not exceeding INR 4,000 crores through an issue of equity shares by way of a qualified institutions placement," it said in an exchange filing.

The move comes as the company looks to manage cash during the COVID-19 pandemic which has hit its operations.


InterGlobe Aviation on July 29 reported a net loss of Rs 2,844.3 crore for the quarter ended June 2020 as coronavirus-led lockdown impacted operations.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more

"The aviation industry is going through a crisis of survival and therefore, our cash balance remains our number one priority. However, we also recognize that major disruptions offer companies opportunities for improvement in product, customer preference, costs and employee engagement," CEO Ronojoy Dutta had said.

The travel restrictions imposed in India and other countries amid the coronavirus pandemic have dealt the aviation sector a huge, unexpected blow. All airlines in India have undertaken cost-cutting measures such as pay cuts, leave without pay and firings of employees in order to conserve cash.
First Published on Aug 10, 2020 06:00 pm